Marchex (MCHX) Research & Development (2010 - 2026)

Marchex (MCHX) has reported Research & Development for 17 consecutive years, with $2.3 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Research & Development fell 27.39% year-over-year to $2.3 million in Q2 2026; TTM through Jun 2026 was $11.6 million, a 7.5% decrease from a year earlier, with the FY2025 full-year figure at $12.5 million, up 0.92% from the prior year.
• Research & Development was $2.3 million for Q2 2026 at Marchex, down from $3.2 million in the prior quarter.
• Over five years, Research & Development peaked at $4.2 million in Q1 2023 and troughed at $2.3 million in Q2 2026.
• A 5-year average of $3.4 million and a median of $3.2 million in 2024 frame the typical range for Research & Development.
• The widest YoY moves for Research & Development: up 36.03% in 2022, down 34.99% in 2022.
• Over 5 years, Research & Development stood at $3.8 million in 2022, then slipped by 17.89% to $3.2 million in 2023, then decreased by 9.9% to $2.8 million in 2024, then climbed by 12.32% to $3.2 million in 2025, then retreated by 27.98% to $2.3 million in 2026.
• The last three Research & Development figures came in at $2.3 million (Q2 2026), $3.2 million (Q4 2025), and $2.9 million (Q3 2025), per Business Quant data.